Genomics-based identification of molecular mechanisms behind the cancer preventive action of phytochemicals: Potential and challenges

Current Pharmaceutical Biotechnology

Volumn 13, Issue 1, 2012, Pages 255-264

  de Kok, Theo M C M ^a   van Breda, Simone G J ^a   Briedé, Jacob J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Antioxidants; Dietary intervention; Genomics; Human cancer prevention; Multiomics phytochemicals; Synergy; Transcriptomics

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CAFFEIC ACID; DIALYLDISULFIDE; FOLIC ACID; GENISTEIN; GREEN TEA EXTRACT; OMEGA 3 FATTY ACID; PHENETHYL ISOTHIOCYANATE; PLANT MEDICINAL PRODUCT; RESVERATROL; SELENIUM; SULFORAPHANE; TOMATO EXTRACT; UNCLASSIFIED DRUG;

CANCER PREVENTION; DRUG MECHANISM; EPIGENETICS; FRUIT VEGETABLE; GENE EXPRESSION; GENOMICS; HUMAN; HUMAN CELL CULTURE; IN VITRO STUDY; METABOLOMICS; NONHUMAN; PROTEOMICS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTOMICS;

ANTICARCINOGENIC AGENTS; BIOLOGICAL AGENTS; DIET; GENOMICS; HUMANS; MOLECULAR EPIDEMIOLOGY; NEOPLASMS; PLANTS;

EID: 84855833517     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920112798868601     Document Type: Review

References (87)

1. World Cancer Research Fund / American Institute for Cancer Research. Food, Nutrition, Physical activity and the Prevention of Cancer: a Global Perspective. Washington DC: AICR. 2007.
2. Amin, A.R.; Kucuk, O.; Khuri, F.R.; Shin, D.M. Perspectives for cancer prevention with natural compounds. J. Clin. Oncol., 2009, 27(16), 2712-2725.
3. Scalbert, A.; Knasmuller, S. Genomic effects of phytochemicals and their implication in the maintenance of health. Br. J. Nutr., 2008, 99 (E Suppl 1), ES1-2.
4. Go, V.L.; Butrum, R.R.; Wong, D.A. Diet, nutrition, and cancer prevention: the postgenomic era. J. Nutr., 2003, 133(11 Suppl 1), 3830S-3836S.
5. Lampe, J.W. Interindividual differences in response to plant-based diets: implications for cancer risk. Am. J. Clin. Nutr., 2009, 89(5), 1553S-1557S.
6. Vineis, P. Diet, genetic susceptibility and carcinogenesis. Public Health Nutr., 2001, 4(2B), 485-491.
7. Kiss, I.; Sandor, J.; Ember, I. Allelic polymorphism of GSTM1 and NAT2 genes modifies dietary-induced DNA damage in colorectal mucosa. Eur. J. Cancer Prev., 2000, 9(6), 429-432.
8. Curtin, K.; Bigler, J.; Slattery, M.L.; Caan, B.; Potter, J.D.; Ulrich, C.M. MTHFR C677T and A1298C polymorphisms: diet, estrogen, and risk of colon cancer. Cancer Epidemiol. Biomarkers Prev., 2004, 13(2), 285-292.
9. London, S.J.; Yuan, J.M.; Chung, F.L.; Gao, Y.T.; Coetzee, G.A.; Ross, R.K.; Yu, M.C. Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China. Lancet, 2000, 356(9231), 724-729.
10. A haplotype map of the human genome. Nature, 2005, 437(7063), 1299-1320.
11. Wang, W.Y.; Barratt, B.J.; Clayton, D.G.; Todd, J.A. Genomewide association studies: theoretical and practical concerns. Nat. Rev. Genet., 2005, 6(2), 109-118.
12. Wilms, L.C.; Boots, A.W.; de Boer, V.C.; Maas, L.M.; Pachen, D.M.; Gottschalk, R.W.; Ketelslegers, H.B.; Godschalk, R.W.; Haenen, G.R.; van Schooten, F.J.; Kleinjans, J.C. Impact of multiple genetic polymorphisms on effects of a 4-week blueberry juice intervention on ex vivo induced lymphocytic DNA damage in human volunteers. Carcinogenesis, 2007, 28(8), 1800-1806.
13. Knasmuller, S.; Nersesyan, A.; Misik, M.; Gerner, C.; Mikulits, W.; Ehrlich, V.; Hoelzl, C.; Szakmary, A.; Wagner, K.H. Use of conventional and-omics based methods for health claims of dietary antioxidants: a critical overview. Br. J. Nutr., 2008, 99 (E Suppl 1), ES3-52.
14. Marioni, J.C.; Mason, C.E.; Mane, S.M.; Stephens, M.; Gilad, Y. RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. Genome Res., 2008, 18(9), 1509-1517.
15. Baron, J.M.; Heise, R.; Blaner, W.S.; Neis, M.; Joussen, S.; Dreuw, A.; Marquardt, Y.; Saurat, J.H.; Merk, H.F.; Bickers, D.R.; Jugert, F.K. Retinoic acid and its 4-oxo metabolites are functionally active in human skin cells in vitro. J. Invest. Dermatol., 2005, 125(1), 143-153.
16. Muller, P.Y.; Netscher, T.; Frank, J.; Stoecklin, E.; Rimbach, G.; Barella, L. Comparative quantification of pharmacodynamic parameters of chiral compounds (RRR-vs. all-rac-alpha tocopherol) by global gene expression profiling. J. Plant. Physiol., 2005, 162(7), 811-817.
17. Brand, W.; Shao, J.; Hoek-van den Hil, E.F.; van Elk, K.N.; Spenkelink, B.; de Haan, L.H.; Rein, M.J.; Dionisi, F.; Williamson, G.; van Bladeren, P.J.; Rietjens, I.M. Stereoselective conjugation, transport and bioactivity of s-and R-hesperetin enantiomers in vitro. J. Agric. Food Chem., 2010, 58(10), 6119-6125.
18. Pierini, R.; Gee, J.M.; Belshaw, N.J.; Johnson, I.T. Flavonoids and intestinal cancers. Br. J. Nutr., 2008, 99 E Suppl 1, ES53-59.
19. Shirai, M.; Kawai, Y.; Yamanishi, R.; Kinoshita, T.; Chuman, H.; Terao, J. Effect of a conjugated quercetin metabolite, quercetin 3-glucuronide, on lipid hydroperoxide-dependent formation of reactive oxygen species in differentiated PC-12 cells. Free Radic. Res., 2006, 40(10), 1047-1053.
20. Castaneda, F.; Rosin-Steiner, S.; Jung, K. Functional genomics analysis of low concentration of ethanol in human hepatocellular carcinoma (HepG2) cells. Role of genes involved in transcriptional and translational processes. Int. J. Med. Sci., 2007, 4(1), 28-35.
21. Ovesna, J.; Slaby, O.; Toussaint, O.; Kodicek, M.; Marsik, P.; Pouchova, V.; Vanek, T. High throughput 'omics' approaches to assess the effects of phytochemicals in human health studies. Br. J. Nutr., 2008, 99 (E Suppl 1), ES127-134.
22. Stefani, M.; Markus, M.A.; Lin, R.C.; Pinese, M.; Dawes, I.W.; Morris, B.J. The effect of resveratrol on a cell model of human aging. Ann. N. Y. Acad. Sci., 2007, 1114, 407-418.
23. van Erk, M.J.; Roepman, P.; van der Lende, T.R.; Stierum, R.H.; Aarts, J.M.; van Bladeren, P.J.; van Ommen, B. Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro. Eur. J. Nutr., 2005, 44(3), 143-156.
24. Kaspar, J.W.; Niture, S.K.; Jaiswal, A.K. Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic. Biol. Med., 2009, 47(9), 1304-1309.
25. Briedé, J.J.; van Delft, J.M.; de Kok, T.M.; van Herwijnen, M.H.; Maas, L.M.; Gottschalk, R.W.; Kleinjans, J.C. Global gene expression analysis reveals differences in cellular responses to hydroxyland superoxide anion radical-induced oxidative stress in caco-2 cells. Toxicol. Sci., 2010, 114(2), 193-203.
26. Halliwell, B. Oxidative stress in cell culture: an under-appreciated problem? FEBS Lett., 2003, 540(1-3), 3-6.
27. Surh, Y.J.; Kundu, J.K.; Na, H.K. Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med., 2008, 74(13), 1526-1539.
28. Vittal, R.; Selvanayagam, Z.E.; Sun, Y.; Hong, J.; Liu, F.; Chin, K.V.; Yang, C.S. Gene expression changes induced by green tea polyphenol (-)-epigallocatechin-3-gallate in human bronchial epithelial 21BES cells analyzed by DNA microarray. Mol. Cancer Ther., 2004, 3(9), 1091-1099.
29. Bevan, R.J.; Mistry, N.; Patel, P.R.; Halligan, E.P.; Dove, R.; Lunec, J. Can vitamin C induce nucleotide excision repair? Support from in vitro evidence. Br J Nutr, 2010, 103(5), 686-695.
30. de Kok, T.M.; van Breda, S.G.; Manson, M.M. Mechanisms of combined action of different chemopreventive dietary compounds: a review. Eur. J. Nutr., 2008, 47 Suppl 2, 51-59.
31. Majewicz, J.; Rimbach, G.; Proteggente, A.R.; Lodge, J.K.; Kraemer, K.; Minihane, A.M. Dietary vitamin C down-regulates inflammatory gene expression in apoE4 smokers. Biochem Biophys. Res. Commun., 2005, 338(2), 951-955.
32. van Breda, S.G.; van Agen, E.; Engels, L.G.; Moonen, E.J.; Kleinjans, J.C.; van Delft, J.H. Altered vegetable intake affects pivotal carcinogenesis pathways in colon mucosa from adenoma patients and controls. Carcinogenesis, 2004, 25(11), 2207-2216.
33. Bakker, G.C.; van Erk, M.J.; Pellis, L.; Wopereis, S.; Rubingh, C.M.; Cnubben, N.H.; Kooistra, T.; van Ommen, B.; Hendriks, H.F. An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach. Am. J. Clin. Nutr., 2010, 91(4), 1044-1059.
34. Radonjic, M.; van Erk, M.J.; Pasman, W.J.; Wortelboer, H.M.; Hendriks, H.F.; van Ommen, B. Effect of body fat distribution on the transcription response to dietary fat interventions. Genes Nutr., 2009, 4(2), 143-149.
35. Pagmantidis, V.; Meplan, C.; van Schothorst, E.M.; Keijer, J.; Hesketh, J.E. Supplementation of healthy volunteers with nutritionally relevant amounts of selenium increases the expression of lymphocyte protein biosynthesis genes. Am. J. Clin. Nutr., 2008, 87(1), 181-189.
36. Esteller, M. The necessity of a human epigenome project. Carcinogenesis, 2006, 27(6), 1121-1125.
37. Lema, C.; Cunningham, M.J. MicroRNAs and their implications in toxicological research. Toxicol. Lett., 2010, 198(2), 100-105.
38. Wilson, A.S.; Power, B.E.; Molloy, P. L. DNA hypomethylation and human diseases. Biochim. Biophys. Acta, 2007, 1775(1), 138-162.
39. Fang, M.; Chen, D.; Yang, C.S. Dietary polyphenols may affect DNA methylation. J. Nutr., 2007, 137(1 Suppl), 223S-228S.
40. Ross, S.A. Nutritional genomic approaches to cancer prevention research. Exp. Oncol., 2007, 29(4), 250-256.
41. Gilbert, E. R.; Liu, D. Flavonoids influence epigenetic-modifying enzyme activity: structure-function relationships and the therapeutic potential for cancer. Curr. Med. Chem., 2010, 17(17), 1756-1768.
42. Davis, C.D.; Ross, S.A. Dietary components impact histone modifications and cancer risk. Nutr. Rev., 2007, 65(2), 88-94.
43. Fraga, M.F.; Ballestar, E.; Villar-Garea, A.; Boix-Chornet, M.; Espada, J.; Schotta, G.; Bonaldi, T.; Haydon, C.; Ropero, S.; Petrie, K.; Iyer, N.G.; Perez-Rosado, A.; Calvo, E.; Lopez, J.A.; Cano, A.; Calasanz, M.J.; Colomer, D.; Piris, M.A.; Ahn, N.; Imhof, A.; Caldas, C.; Jenuwein, T.; Esteller, M. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat. Genet., 2005, 37(4), 391-400.
44. Fang, M.Z.; Wang, Y.; Ai, N.; Hou, Z.; Sun, Y.; Lu, H.; Welsh, W.; Yang, C.S. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res., 2003, 63(22), 7563-7570.
45. Chuang, J.C.; Yoo, C.B.; Kwan, J.M.; Li, T.W.; Liang, G.; Yang, A.S.; Jones, P.A. Comparison of biological effects of nonnucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine. Mol. Cancer Ther., 2005, 4(10), 1515-1520.
46. Lee, W.J.; Shim, J.Y.; Zhu, B.T. Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol. Pharmacol., 2005, 68(4), 1018-1030.
47. Fang, M.Z.; Jin, Z.; Wang, Y.; Liao, J.; Yang, G.Y.; Wang, L.D.; Yang, C.S. Promoter hypermethylation and inactivation of O(6)-methylguanine-DNA methyltransferase in esophageal squamous cell carcinomas and its reactivation in cell lines. Int. J. Oncol., 2005, 26(3), 615-622.
48. Basak, S.; Pookot, D.; Noonan, E.J.; Dahiya, R. Genistein downregulates androgen receptor by modulating HDAC6-Hsp90 chaperone function. Mol. Cancer Ther., 2008, 7(10), 3195-3202.
49. Majid, S.; Kikuno, N.; Nelles, J.; Noonan, E.; Tanaka, Y.; Kawamoto, K.; Hirata, H.; Li, L.C.; Zhao, H.; Okino, S.T.; Place, R.F.; Pookot, D.; Dahiya, R. Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. Cancer Res., 2008, 68(8), 2736-2744.
50. Lee, W.J.; Zhu, B.T. Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis, 2006, 27(2), 269-277.
51. Davis, C.D.; Uthus, E.O. Dietary folate and selenium affect dimethylhydrazine-induced aberrant crypt formation, global DNA methylation and one-carbon metabolism in rats. J. Nutr., 2003, 133(9), 2907-2914.
52. Atalay, M.; Gordillo, G.; Roy, S.; Rovin, B.; Bagchi, D.; Bagchi, M.; Sen, C.K. Anti-angiogenic property of edible berry in a model of hemangioma. FEBS Lett., 2003, 544(1-3), 252-257.
53. Duthie, S.J. Folate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis. J. Inherit. Metab. Dis., 2010, 51(2), 290-304.
54. Myzak, M.C.; Karplus, P.A.; Chung, F.L.; Dashwood, R.H. A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res, 2004, 64(16), 5767-5774.
55. Myzak, M.C.; Hardin, K.; Wang, R.; Dashwood, R.H.; Ho, E. Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells. Carcinogenesis, 2006, 27(4), 811-819.
56. Myzak, M.C.; Dashwood, W.M.; Orner, G.A.; Ho, E.; Dashwood, R.H. Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice. FASEB J., 2006, 20(3), 506-508.
57. Myzak, M.C.; Dashwood, R.H. Histone deacetylases as targets for dietary cancer preventive agents: lessons learned with butyrate, diallyl disulfide, and sulforaphane. Curr. Drug. Targets, 2006, 7(4), 443-452.
58. Dashwood, R.H.; Ho, E. Dietary histone deacetylase inhibitors: from cells to mice to man. Semin. Cancer Biol., 2007, 17(5), 363-369.
59. Wang, L.G.; Liu, X. M.; Fang, Y.; Dai, W.; Chiao, F.B.; Puccio, G.M.; Feng, J.; Liu, D.; Chiao, J.W. De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc. Int. J. Oncol., 2008, 33(2), 375-380.
60. Wang, L.G.; Beklemisheva, A.; Liu, X.M.; Ferrari, A.C.; Feng, J.; Chiao, J.W. Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer. Mol. Carcinog., 2007, 46(1), 24-31.
61. Druesne, N.; Pagniez, A.; Mayeur, C.; Thomas, M.; Cherbuy, C.; Duee, P.H.; Martel, P.; Chaumontet, C. Diallyl disulfide (DADS) increases histone acetylation and p21(waf1/cip1) expression in human colon tumor cell lines. Carcinogenesis, 2004, 25(7), 1227-1236.
62. Lea, M.A.; Randolph, V.M. Induction of histone acetylation in rat liver and hepatoma by organosulfur compounds including diallyl disulfide. Anticancer Res., 2001, 21(4A), 2841-2845.
63. Tsang, W.P.; Kwok, T.T. Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells. J. Nutr. Biochem., 2010, 21(2), 140-146.
64. Davis, C.D.; Ross, S.A. Evidence for dietary regulation of microRNA expression in cancer cells. Nutr. Rev., 2008, 66(8), 477-482.
65. Zhang, J.; Du, Y.; Wu, C.; Ren, X.; Ti, X.; Shi, J.; Zhao, F.; Yin, H. Curcumin promotes apoptosis in human lung adenocarcinoma cells through miR-186* signaling pathway. Oncol. Rep., 2010, 24(5), 1217-1223.
66. Kim, H. New nutrition, proteomics, and how both can enhance studies in cancer prevention and therapy. J. Nutr., 2005, 135(11), 2715-2718.
67. Mouat, M.F.; Kolli, K.; Orlando, R.; Hargrove, J.L.; Grider, A. The effects of quercetin on SW480 human colon carcinoma cells: a proteomic study. Nutr. J., 2005, 4, 11.
68. Dihal, A.A.; van der Woude, H.; Hendriksen, P.J.; Charif, H.; Dekker, L.J.; Ijsselstijn, L.; de Boer, V.C.; Alink, G.M.; Burgers, P.C.; Rietjens, I.M.; Woutersen, R.A.; Stierum, R.H. Transcriptome and proteome profiling of colon mucosa from quercetin fed F344 rats point to tumor preventive mechanisms, increased mitochondrial fatty acid degradation and decreased glycolysis. Proteomics, 2008, 8(1), 45-61.
69. Roy, P.; Nigam, N.; George, J.; Srivastava, S.; Shukla, Y. Induction of apoptosis by tea polyphenols mediated through mitochondrial cell death pathway in mouse skin tumors. Cancer Biol. Ther., 2009, 8(13), 1281-1287.
70. Hoelzl, C.; Glatt, H.; Meinl, W.; Sontag, G.; Haidinger, G.; Kundi, M.; Simic, T.; Chakraborty, A.; Bichler, J.; Ferk, F.; Angelis, K.; Nersesyan, A.; Knasmuller, S. Consumption of Brussels sprouts protects peripheral human lymphocytes against 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and oxidative DNAdamage: results of a controlled human intervention trial. Mol. Nutr. Food Res., 2008, 52(3), 330-341.
71. Weissinger, E. M.; Nguyen-Khoa, T.; Fumeron, C.; Saltiel, C.; Walden, M.; Kaiser, T.; Mischak, H.; Drueke, T.B.; Lacour, B.; Massy, Z.A. Effects of oral vitamin C supplementation in hemodialysis patients: a proteomic assessment. Proteomics, 2006, 6(3), 993-1000.
72. Aldred, S.; Sozzi, T.; Mudway, I.; Grant, M.M.; Neubert, H.; Kelly, F.J.; Griffiths, H.R. Alpha tocopherol supplementation elevates plasma apolipoprotein A1 isoforms in normal healthy subjects. Proteomics, 2006, 6(5), 1695-1703.
73. Solanky, K.S.; Bailey, N.J.; Beckwith-Hall, B. M.; Bingham, S.; Davis, A.; Holmes, E.; Nicholson, J.K.; Cassidy, A. Biofluid 1H NMR-based metabonomic techniques in nutrition research-metabolic effects of dietary isoflavones in humans. J. Nutr. Biochem., 2005, 16(4), 236-244.
74. Solanky, K.S.; Bailey, N.J.; Beckwith-Hall, B.M.; Davis, A.; Bingham, S.; Holmes, E.; Nicholson, J.K.; Cassidy, A. Application of biofluid 1H nuclear magnetic resonance-based metabonomic techniques for the analysis of the biochemical effects of dietary isoflavones on human plasma profile. Anal. Biochem., 2003, 323(2), 197-204.
75. Wong, M.C.; Emery, P.W.; Preedy, V.R.; Wiseman, H. Health benefits of isoflavones in functional foods? Proteomic and metabonomic advances. Inflammopharmacology, 2008, 16(5), 235-239.
76. Fardet, A.; Llorach, R.; Orsoni, A.; Martin, J.F.; Pujos-Guillot, E.; Lapierre, C.; Scalbert, A. Metabolomics provide new insight on the metabolism of dietary phytochemicals in rats. J. Nutr., 2008, 138(7), 1282-1287.
77. Sorani, M.D.; Ortmann, W.A.; Bierwagen, E.P.; Behrens, T.W. Clinical and biological data integration for biomarker discovery. Drug Discov. Today, 2010, 15(17-18), 741-8.
78. Garcia-Canas, V.; Simo, C.; Leon, C.; Cifuentes, A. Advances in Nutrigenomics research: novel and future analytical approaches to investigate the biological activity of natural compounds and food functions. J. Pharm. Biomed. Anal., 2010, 51(2), 290-304.
79. Conlon, E.M. A Bayesian mixture model for metaanalysis of microarray studies. Funct. Integr. Genomics, 2008, 8(1), 43-53.
80. Hebels, D.G.; Briede, J.J.; Khampang, R.; Kleinjans, J.C.; de Kok, T.M. Radical mechanisms in nitrosamine-and nitrosamide-induced whole-genome gene expression modulations in Caco-2 cells. Toxicol. Sci., 2010, 116(1), 194-205.
81. Keijer, J.; van Helden, Y.G.; Bunschoten, A.; van Schothorst, E.M. Transcriptome analysis in benefit-risk assessment of micronutrients and bioactive food components. Mol. Nutr. Food Res., 2010, 54(2), 240-248.
82. van Dijk, S.J.; Feskens, E.J.; Bos, M.B.; Hoelen, D.W.; Heijligenberg, R.; Bromhaar, M.G.; de Groot, L.C.; de Vries, J.H.; Muller, M.; Afman, L.A. A saturated fatty acid-rich diet induces an obesity-linked proinflammatory gene expression profile in adipose tissue of subjects at risk of metabolic syndrome. Am. J. Clin. Nutr., 2009, 90(6), 1656-1664.
83. van Erk, M.J.; Blom, W.A.; van Ommen, B.; Hendriks, H.F. Highprotein and high-carbohydrate breakfasts differentially change the transcriptome of human blood cells. Am J Clin. Nutr., 2006, 84(5), 1233-1241.
84. Daston, G.P. Gene expression, dose-response, and phenotypic anchoring: applications for toxicogenomics in risk assessment. Toxicol. Sci., 2008, 105(2), 233-234.
85. Merlo, D.F.; Wild, C.P.; Kogevinas, M.; Kyrtopoulos, S.; Kleinjans, J.C. NewGeneris: a European study on maternal diet during pregnancy and child health. Cancer Epidemiol Biomarkers Prev., 2009, 18(1), 5-10.
86. Envirogenomarkers, The envirogenomarkers consortium http://www.envirogenomarkers.net/ (accessed June 2010).
87. Lambert, J.D.; Sang, S.; Yang, C.S. Possible controversy over dietary polyphenols: benefits vs risks. Chem. Res. Toxicol., 2007, 20(4), 583-585.